Unravelling the in vivo dynamics of liposomes: Insights into biodistribution and cellular membrane interactions
- PMID: 38599316
- DOI: 10.1016/j.lfs.2024.122616
Unravelling the in vivo dynamics of liposomes: Insights into biodistribution and cellular membrane interactions
Abstract
Liposomes, as a colloidal drug delivery system dating back to the 1960s, remain a focal point of extensive research and stand as a highly efficient drug delivery method. The amalgamation of technological and biological advancements has propelled their evolution, elevating them to their current status. The key attributes of biodegradability and biocompatibility have been instrumental in driving substantial progress in liposome development. Demonstrating a remarkable ability to surmount barriers in drug absorption, enhance stability, and achieve targeted distribution within the body, liposomes have become pivotal in pharmaceutical research. In this comprehensive review, we delve into the intricate details of liposomal drug delivery systems, focusing specifically on their pharmacokinetics and cell membrane interactions via fusion, lipid exchange, endocytosis etc. Emphasizing the nuanced impact of various liposomal characteristics, we explore factors such as lipid composition, particle size, surface modifications, charge, dosage, and administration routes. By dissecting the multifaceted interactions between liposomes and biological barriers, including the reticuloendothelial system (RES), opsonization, enhanced permeability and retention (EPR) effect, ATP-binding cassette (ABC) phenomenon, and Complement Activation-Related Pseudoallergy (CARPA) effect, we provide a deeper understanding of liposomal behaviour in vivo. Furthermore, this review addresses the intricate challenges associated with translating liposomal technology into practical applications, offering insights into overcoming these hurdles. Additionally, we provide a comprehensive analysis of the clinical adoption and patent landscape of liposomes across diverse biomedical domains, shedding light on their potential implications for future research and therapeutic developments.
Keywords: Biodistribution; Clinical trials and patents; EPR effect; Liposomal cellular uptake; Liposomes; Pharmacokinetics; Reticuloendothelial system.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Prof. Umme Hani reports financial support was provided by King Khalid University.
Similar articles
-
Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate.Life Sci. 2022 Jul 1;300:120574. doi: 10.1016/j.lfs.2022.120574. Epub 2022 Apr 23. Life Sci. 2022. PMID: 35469915 Review.
-
A Sojourn on Liposomal Delivery System: Recent Advances and Future Prospects.Assay Drug Dev Technol. 2023 Feb-Mar;21(2):48-64. doi: 10.1089/adt.2022.089. Epub 2023 Feb 28. Assay Drug Dev Technol. 2023. PMID: 36856471 Review.
-
Liposomes of Quantum Dots Configured for Passive and Active Delivery to Tumor Tissue.Nano Lett. 2019 Sep 11;19(9):5844-5852. doi: 10.1021/acs.nanolett.9b01027. Epub 2019 Aug 22. Nano Lett. 2019. PMID: 31424944
-
Advances and Challenges of Liposome Assisted Drug Delivery.Front Pharmacol. 2015 Dec 1;6:286. doi: 10.3389/fphar.2015.00286. eCollection 2015. Front Pharmacol. 2015. PMID: 26648870 Free PMC article. Review.
-
Future directions of liposome- and immunoliposome-based cancer therapeutics.Semin Oncol. 2004 Dec;31(6 Suppl 13):196-205. doi: 10.1053/j.seminoncol.2004.08.009. Semin Oncol. 2004. PMID: 15717745 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources